Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F vom Dorp

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Der Urologe. Ausg. A|May 20, 2006
[Value of systemic chemotherapy in bladder cancer]P J Goebell, F vom Dorp, H Rübben
Der Urologe. Ausg. A|October 13, 2010
[Non-muscle-invasive transitional cell carcinoma. Is BCG still a necessary part of treatment?]F vom Dorp, S Tschirdewahn, H Rübben, et al.
Der Urologe. Ausg. A|January 6, 2007
[The management of cutaneous metastases]C Börgermann, F Vom Dorp, S Krege, et al.
Der Urologe. Ausg. A|October 16, 2014
[Non-muscle invasive bladder cancer: safety of postoperative EMDA-assisted instillation of mitomycin]C Rehme, C Niedworok, H Rübben, et al.
Der Urologe. Ausg. A|May 25, 2005
[Molecular biology approach to explain lymphatic metastasis]F Vom Dorp, B Wullich, E Gulbins, et al.
Der Urologe. Ausg. A|March 3, 2011
[Exfoliative urine cytology in the treatment of bladder cancer]S Tschirdewahn, F Vom Dorp, H Rübben, et al.
Der Urologe. Ausg. A|September 13, 2013
[Urine cytology - update 2013. A systematic review of recent literature]M Böhm, F vom Dorp, M Schostak, et al.
Der Urologe. Ausg. A|October 21, 2010
[Early detection of prostate cancer: is serum PSA testing alone sufficient?]C Börgermann, F Vom Dorp, G Breuer, et al.
Der Urologe. Ausg. A|December 11, 2008
[Impact of surgery for residual tumors after chemotherapy]J Hess, F vom Dorp, M Becker, et al.
Der Urologe. Ausg. A|July 21, 2007
[Prognostic factors of urinary bladder carcinoma]F vom Dorp, T Jaeger, K Schmidt, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Der Urologe. Ausg. A|May 20, 2006
[Value of systemic chemotherapy in bladder cancer]P J Goebell, F vom Dorp, H Rübben
Der Urologe. Ausg. A|October 13, 2010
[Non-muscle-invasive transitional cell carcinoma. Is BCG still a necessary part of treatment?]F vom Dorp, S Tschirdewahn, H Rübben, et al.
Der Urologe. Ausg. A|January 6, 2007
[The management of cutaneous metastases]C Börgermann, F Vom Dorp, S Krege, et al.
Der Urologe. Ausg. A|October 16, 2014
[Non-muscle invasive bladder cancer: safety of postoperative EMDA-assisted instillation of mitomycin]C Rehme, C Niedworok, H Rübben, et al.
Der Urologe. Ausg. A|May 25, 2005
[Molecular biology approach to explain lymphatic metastasis]F Vom Dorp, B Wullich, E Gulbins, et al.
Der Urologe. Ausg. A|March 3, 2011
[Exfoliative urine cytology in the treatment of bladder cancer]S Tschirdewahn, F Vom Dorp, H Rübben, et al.
Der Urologe. Ausg. A|September 13, 2013
[Urine cytology - update 2013. A systematic review of recent literature]M Böhm, F vom Dorp, M Schostak, et al.
Der Urologe. Ausg. A|October 21, 2010
[Early detection of prostate cancer: is serum PSA testing alone sufficient?]C Börgermann, F Vom Dorp, G Breuer, et al.
Der Urologe. Ausg. A|December 11, 2008
[Impact of surgery for residual tumors after chemotherapy]J Hess, F vom Dorp, M Becker, et al.
Der Urologe. Ausg. A|July 21, 2007
[Prognostic factors of urinary bladder carcinoma]F vom Dorp, T Jaeger, K Schmidt, et al.
Pageof 6